Avaliação da massa ossea em usuarias do sistema intra-uterino liberador de levonorgestrel (SIU-LNG)
AUTOR(ES)
Ximena Espejo Arce
DATA DE PUBLICAÇÃO
2005
RESUMO
BACKGROUND: There are concerns about the effect of hormonal contraceptives on bone mineral density (BMD) but there is currently no information available on the effect of the levonorgestrel-releasing intrauterine system (LNG-IUS, Mirenaâ) on BMD. The objective of this study was to compare the BMD of Mirenaâ users with that of controls using the TCu380A intrauterine device (IUD). MATERIALS AND METHODS: A cross-sectional study paired 53 women, aged 25 to 51, who had been using the LNG-IUS for 7 years, with 53 IUD users, according to age (± 1 year) and body mass index (BMI; kg/m2) (± 1). BMD was evaluated at the midshaft of the ulna and the distal radius of the nondominant forearm using double X-ray absorptiometry. RESULTS: Mean age of women was 34 years. BMI was slightly over 25 in both groups. Estradiol was 98.2 ± 12.7 pg/ml (mean ± SD). Mean BMD was 0.471 ± 0.058 and 0.467 ± 0.050 and 0.409 ± 0.009 and 0.411 ± 0.009 at the midshaft of the ulna and distal radius in Mirena and IUD users, respectively (mean ± SD), without significant differences. CONCLUSIONS: Women aged 25 to 51, using the LNG-IUS for seven years, had a mean BMD similar to that of the control group of TCu380A IUD users
ASSUNTO(S)
anticoncepcionais dispositivos intra-uterinos dispositivos intrauterinos densitometria anticoncepção contraceptivos
ACESSO AO ARTIGO
http://libdigi.unicamp.br/document/?code=vtls000376502Documentos Relacionados
- Avaliação citologica e da flora vaginal em usuarias de sistema intra-uterino liberador de levonorgestrel (SIU-LNG) por longo periodo de tempo
- Indicações e razões para descontinuação do sistema intra-uterino liberador de levanogestrel (SIU-LNG)
- Sistema intra-uterino liberador de levonorgestrel
- Correlação entre histologia endometrial e padrão de sangramento em usuarias do sistema intra-uterino liberador de levonorgestrel
- Aceitabilidade, desempenho clinico e padrão de sangramento em mulheres usuarias do sistema intra-uterino liberador de levonorgestrel